SmartVax In The News

Congratulations to the Winners of the 19th Research Australia Awards

The nation’s brightest scientific minds and advocates have been recognised in Research Australia’s 19th Health and Medical Research Awards, celebrating the extraordinary researchers, philanthropists and community champions who are leading work with transformational impact for patients and the health sector. 

22 December 2022 – INSPIRE Issue 26: Clinical Researchers and the Healthcare System

AusVaxSafety Wins Data Innovation Award

AusVaxSafety has been awarded the Data Innovation Award at Research Australia’s 19th Annual Health and Medical Research Awards for their work in delivering a nationally consistent vaccine safety surveillance in near-real time from the first day of the COVID-19 vaccine rollout, the largest and most complex immunisation program ever delivered in Australia. 

SmartVax is an integral part and one of the key data sources for AusVaxSafety.

Research Australia’s Health and Medical Research (HMR) Awards recognise the outstanding efforts and achievements of individuals and teams who drive and support the opportunities that health and medical innovation bring to each and every one of our lives.

8 December 2022

How many Australians have had short-Term reactions to COVID-19 vaccines?

More than half of Australians experienced a reaction to at least one of their first two doses of a COVID-19 vaccine, but less than 1 per cent sought medical advice for it.
Those are the findings of a new study by AusVaxSafety, published in the Medical Journal of Australia, which surveyed more than three million Aussies after they were vaccinated.

11 July 2022 – Nine News

Real-world Aussie safety data on COVID-19 vax for young kids 'reassuring'

Recent data from AusVaxSafety shows children aged 5–11 years are reporting fewer side effects following COVID-19 vaccination than older Australians, with local reactions (pain at injection site, swelling, redness and itching) followed by headache and fatigue being the most commonly reported side effects among this age group.
They were also less likely to visit a doctor or emergency department following their Pfizer dose 1 vaccination.

17 January 2022 – Australian Doctor News

Real-time vax safety monitoring for pharmacies may be coming soon

Pharmacy and medical researchers have collaborated with industry partners to pilot an active vaccine safety surveillance program for patients immunised in pharmacies.

The pilot was led by the University of Western Australia, in partnership with SmartVax, MedAdvisor and the Queensland University of Technology, with support from the Pharmaceutical Society of Western Australia, via the JM O’Hara Research Fund.

04 February 2021 – AJP

Program to monitor the safety of pharmacy vaccines including COVID

A successful Australian pilot study led by The University of Western Australia could lead to monitoring the safety of vaccines administered in pharmacies across Australia, including the safety of COVID-19 vaccines.

01 February 2021 – University of Western Australia

Adverse events from Pharmacy Vaccinations To Be Tracked in Real Time

SmartVax founder Dr Alan Leeb wants to give pharmacists the same ability as GPs to get involved in surveillance.

Last month, the Pharmaceutical Society of WA announced it was funding a trial of the SmartVax safety surveillance program which will cover vaccinations administered at 30 pharmacies in WA, with the aim of rolling it out nationally in future.

9 April 2020 – AusDoc

New Program to Monitor Adverse Effects of New Vaccines

A new Australian pilot program led by The University of Western Australia, in partnership with SmartVax, MedAdvisor and the Queensland University of Technology, will monitor the effects of flu vaccines administered by pharmacists this flu season. When the novel COVID-19 vaccine becomes available, the program could monitor its effects through pharmacies.

24 March 2020 – Mirage News

9 out of 10 babies exposed to peanuts

Almost nine out of ten Australian babies have been introduced to peanuts and other food allergens before their first birthdays, a GP-based study shows.

In the research, 86% of 1940 parents replying to the survey (response rate 57%) had adopted updated advice to expose infants early to peanuts and other foods such as dairy and egg.

7 February 2020 – AusDoc.PLUS